Tela Historical Income Statement
| TELA Stock | USD 2.94 0.07 2.33% |
Historical analysis of Tela Bio income statement accounts such as Selling And Marketing Expenses of 30.6 M, Total Revenue of 61.4 M, Gross Profit of 42.1 M or Other Operating Expenses of 58 M can show how well Tela Bio performed in making a profits. Evaluating Tela Bio income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Tela Bio's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining Tela Bio latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Tela Bio is a good buy for the upcoming year.
Tela |
About Tela Income Statement Analysis
Tela Bio Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Tela Bio shareholders. The income statement also shows Tela investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
Tela Bio Income Statement Chart
Add Fundamental
Total Revenue
Total revenue comprises all receipts Tela Bio generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.Gross Profit
Gross profit is a required income statement account that reflects total revenue of Tela Bio minus its cost of goods sold. It is profit before Tela Bio operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.Cost Of Revenue
Cost of Revenue is found on Tela Bio income statement and represents the costs associated with goods and services Tela Bio provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.Most accounts from Tela Bio's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Tela Bio current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Tela Bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. For information on how to trade Tela Stock refer to our How to Trade Tela Stock guide.At present, Tela Bio's Depreciation And Amortization is projected to increase significantly based on the last few years of reporting. The current year's Total Revenue is expected to grow to about 61.4 M, whereas Net Interest Income is forecasted to decline to (5.3 M).
| 2023 | 2024 (projected) | Depreciation And Amortization | 808K | 850.9K | Interest Income | 3.3M | 2.6M |
Tela Bio income statement Correlations
Click cells to compare fundamentals
Tela Bio Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Tela Bio income statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Net Interest Income | (3.6M) | (3.6M) | (3.6M) | (4.1M) | (5.1M) | (5.3M) | |
| Depreciation And Amortization | 351K | 525K | 535K | 1.2M | 808K | 850.9K | |
| Interest Expense | 3.6M | 3.6M | 3.6M | 4.1M | 5.2M | 4.1M | |
| Selling General Administrative | 6.2M | 10.1M | 12.5M | 13.9M | 14.9M | 10.6M | |
| Selling And Marketing Expenses | 18.1M | 22.1M | 29.1M | 43.3M | 59.7M | 30.6M | |
| Total Revenue | 15.4M | 18.2M | 29.5M | 41.4M | 58.5M | 61.4M | |
| Gross Profit | 9.3M | 11.2M | 18.8M | 27.0M | 40.1M | 42.1M | |
| Other Operating Expenses | 34.6M | 43.5M | 58.9M | 80.4M | 102.5M | 58.0M | |
| Operating Income | (19.2M) | (25.3M) | (29.5M) | (39.0M) | (44.1M) | (41.9M) | |
| Net Income From Continuing Ops | (22.4M) | (28.8M) | (33.3M) | (44.3M) | (43.8M) | (45.9M) | |
| Ebit | (19.2M) | (25.2M) | (29.7M) | (40.2M) | (41.4M) | (43.5M) | |
| Research Development | 4.2M | 4.3M | 6.7M | 8.9M | 9.6M | 6.9M | |
| Ebitda | (18.8M) | (24.7M) | (29.1M) | (39.1M) | (40.6M) | (42.7M) | |
| Cost Of Revenue | 6.2M | 7.0M | 10.7M | 14.4M | 18.3M | 10.0M | |
| Total Operating Expenses | 28.4M | 36.5M | 48.3M | 66.1M | 84.2M | 48.1M | |
| Reconciled Depreciation | 582K | 525K | 535K | 1.2M | 854K | 894.5K | |
| Income Before Tax | (22.4M) | (28.8M) | (33.3M) | (44.3M) | (46.7M) | (49.0M) | |
| Total Other Income Expense Net | (3.3M) | (3.5M) | (3.8M) | (5.3M) | (2.6M) | (2.7M) | |
| Net Income Applicable To Common Shares | (30.2M) | (28.8M) | (33.3M) | (44.3M) | (39.9M) | (41.9M) | |
| Net Income | (25.8M) | (31.9M) | (36.1M) | (44.3M) | (46.7M) | (49.0M) | |
| Income Tax Expense | 3.4M | 3.1M | 2.8M | 41K | 640.1K | 608.1K |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Tela Bio offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Tela Bio's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Tela Bio Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Tela Bio Stock:Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Tela Bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. For information on how to trade Tela Stock refer to our How to Trade Tela Stock guide.You can also try the Stocks Directory module to find actively traded stocks across global markets.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Tela Bio. If investors know Tela will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Tela Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.69) | Revenue Per Share 2.789 | Quarterly Revenue Growth 0.259 | Return On Assets (0.41) | Return On Equity (3.42) |
The market value of Tela Bio is measured differently than its book value, which is the value of Tela that is recorded on the company's balance sheet. Investors also form their own opinion of Tela Bio's value that differs from its market value or its book value, called intrinsic value, which is Tela Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Tela Bio's market value can be influenced by many factors that don't directly affect Tela Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Tela Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Tela Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Tela Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.